文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

核酸作为脓毒症预后评估生物标志物的研究进展

[Progress of nucleic acid as biomarkers on the prognostic evaluation of sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论综述指出cf-DNA、mtDNA、miRNA和lncRNA与脓毒症病理过程及预后相关,但尚无标志物能同时达到100%敏感度和特异度。

脓毒症是感染引起的难治性危重症,临床上使用相关生物学指标结合患者生理状态和个人经验来监测病情和评估预后,有助于防止病情发展和降低病死率。新的脓毒症诊疗指南不断出现,以实现早期诊断和及时治疗并改善患者预后,但早期识别重症患者和预测预后仍然困难。目前关于脓毒症生物标志物的基础和临床研究不断涌现,但尚无标志物能同时达到100%的敏感度和特异度。近年来,利用核酸评估脓毒症患者病情和预测预后受到研究者越来越多的关注。本文综述了游离DNA(cf-DNA)、血浆线粒体DNA(mtDNA)、微小RNA(miRNA)和长链非编码RNA(lncRNA)在脓毒症病理过程中的作用及其与预后的关系,以期更深入地理解脓毒症发生发展机制,并寻找评估脓毒症病情和预后的新标志物。

要点

  • 脓毒症是感染引起的难治性危重症,临床用相关生物学指标结合生理状态和个人经验监测病情、评估预后。
  • 新指南不断出现以实现早期诊断和及时治疗并改善预后,但早期识别重症患者和预测预后仍然困难。
  • 脓毒症生物标志物的基础和临床研究不断涌现,但尚无标志物能同时达到100%的敏感度和特异度。
  • cf-DNA、血浆mtDNA、miRNA和lncRNA在脓毒症病理过程中的作用及其与预后的关系受到越来越多关注。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is a refractory critical illness caused by infection. Clinicians use relevant biological indicators, combined with the physiological status and personal experience of sepsis patients to monitor the condition and assess the prognosis, which helps in preventing the development of the condition and reduce the mortality. New guidelines for the diagnosis and treatment of sepsis continue to emerge for early diagnosis and timely treatment and improve patient prognosis. However, it is still difficult to identify severe patients at an early stage and predict prognosis. At present, a series of basic and clinical studies on sepsis biomarkers are emerging, but no marker can achieve 100% sensitivity and specificity at the same time. In recent years, the use of nucleic acids to assess the condition of patients with sepsis and predict the prognosis has received increasing attention from researchers. This article reviews the role of cell-free DNA (cf-DNA), plasma mitochondrial DNA (mtDNA), microRNA (miRNA), and long-chain noncoding RNA (lncRNA) in the pathological process of sepsis and its relationship with prognosis, with a view of providing a deeper understanding of the mechanism of sepsis occurrence and development, as well as finding new markers for evaluating the condition and prognosis of sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xiao X, Xu W. [Progress of nucleic acid as biomarkers on the prognostic evaluation of sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32788030. doi:10.3760/cma.j.cn121430-20200512-00378

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。